Condition

Platinum-resistant Recurrent Ovarian Cancer clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Evaluating APG-2449 for treating advanced ovarian cancer and solid tumors

  This study is testing a new drug called APG-2449 to see if it can safely help people with advanced ovarian cancer and other solid tumors, both on its own and when combined with another treatment.

  Recruiting Phase 1 Ascentage Pharma Group Inc. · Guangzhou, Guangdong · NCT06687070

• Combining B013 with Paclitaxel for treating platinum-resistant recurrent ovarian cancer

  This study is testing if a new drug called B013, when combined with Paclitaxel, can help people with platinum-resistant recurrent ovarian cancer feel better.

  Recruiting at 17 sites Phase 2 Shanghai Jiaolian Drug Research and Development Co., Ltd · Beijing and 16 other locations · NCT06434610

Related topics

Quick answers

How many Platinum-resistant Recurrent Ovarian Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →